Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Genetic Testing Market: By Test, By Application, By Sample Type, By End-user and Region
The genetic testing market size was valued at US$ 12,253.8 million in 2023 and is poised to grow at a CAGR of 11.7% from 2024-2030. Genetic testing is a type of medical test that identifies changes in genes, chromosomes, or proteins, from which a genetic counselor will access the results. The result of a genetic test can either confirm the presence of a genetic disorder or indicate the absence of the possibility; moreover, it contributes to determining a person's chance of passing on or developing an inherited genetic disorder.
Genetic testing and spending on that testing have grown rapidly since the mapping of the human genome editing in 2003. More than 77,000 genetic tests are currently in use across the globe, and more are being developed. Genetic Testing continues to play a significant role in cancer, prenatal, and newborn screening, particularly in regions where genetic diseases are prevalent. The market encompasses various activities related to the extraction, processing of genomes, and sale of Genetic Testing kits and Genetic Testing-based products. The primary driver is the demand for Genetic Testing in the prevalence of diseases like cancer and rare diseases.
According to Orphanet, out of 6,172 unique rare diseases 71.9% of which are genetic and 69.9% are exclusively pediatric onset. Moreover, according to WHO, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, thus testing and screening for it becomes essential. This is where genetic testing comes in place. Restraints include stringent regulations, privacy issues, the high cost of testing, and the lack of reimbursement policies in developing countries.
However, many countries, including Italy, and Australia have mandated the use of genetic testing for prenatal and newborn screening, which increases the market growth. Increasing healthcare access and rise in disposable income in developing countries, the rising popularity of genetic testing and technological advancements present growth opportunities for Genetic Testing-based treatments.
Study Period
2024-2030Base Year
2023CAGR
11.7%Largest Market
North AmericaFastest Growing Market
Europe
According to the World Economic Forum, Collectively, about 350 million people worldwide suffer from rare diseases, Around 80% of rare diseases have a genetic cause, almost 70% of which present in childhood. All these can be screened using genetic testing and can be treated using gene therapies. The rising number of genetic conditions is a prime factor fuelling the demand for Genetic Testing. Additionally, Technological advancements in genetic testing include the development of next-generation sequencing and chromosomal microarray analysis, which transforms the determination of structural and numerical abnormalities in chromosomes and, in turn, leads to the detection of various rare genomic and genetic disorders and acts as a main driver for the market.
Next-generation sequencing (NGS) and CRISPR have evolved as a powerful tool for providing a deeper and more precise insight into the molecular underpinnings of individual tumours and specific receptors. One of the big drivers of this market is precision medicine or personalized medicine. In 2020, more than 250 personalized medicines were approved and available in the market. Thus, all the companies compete to provide the facility to avail genetic testing which increases the shift of treatment towards personalized medicine.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 12,253.8 million |
Market CAGR |
11.7% |
By Test Type |
|
By Sample |
|
By Application |
|
By End User |
|
By Region |
|
Download Free Sample Report
The global genetic testing market size was valued at US$ 12,253.8 million in 2023 and is poised to grow at a CAGR of 11.7% from 2024-2030.
The major key players operating in the genetic testing market are 10X Genomics, Inc., Quest Diagnostics Incorporated, QIAGEN N.V., Myriad Genetics Inc., Bio-Rad Laboratories Inc. Hoffmann-La Roche Ltd, Eurofins Scientific, Blueprint Genetics, Illumina Inc., BGI Genomics, PerkinElmer Inc., Abbott Laboratories, Thermo Fisher Scientific Inc.
North America is the fastest-growing region for genetic testing market
The primary driver is the demand for Genetic Testing in the prevalence of diseases like cancer and rare diseases coupled with newborn screening and the rise in precision medicine.
1.Executive Summary |
2.Global Genetic Testing Market Introduction |
2.1.Global Genetic Testing Market - Taxonomy |
2.2.Global Genetic Testing Market - Definitions |
2.2.1.Test Type |
2.2.2.Sample |
2.2.3.Application |
2.2.4.End User |
2.2.5.Region |
3.Global Genetic Testing Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Genetic Testing Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Genetic Testing Market By Test Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Cytogenetic Testing |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Biochemical Testing |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Molecular Testing |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
6.Global Genetic Testing Market By Sample, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Blood |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Hair |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Saliva |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Others |
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
7.Global Genetic Testing Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Predictive and Presymptomatic Testing |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Carrier Testing |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Prenatal and Newborn Screening |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Pharmacogenomic Testing |
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Cancer Screening |
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
7.6. Forensic |
7.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.6.3. Market Opportunity Analysis |
7.7. Others |
7.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.7.3. Market Opportunity Analysis |
8.Global Genetic Testing Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. Hospitals |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Diagnostic Laboratories |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Academic and Research Institutes |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
9.Global Genetic Testing Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. North America |
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Europe |
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Asia Pacific (APAC) |
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Middle East and Africa (MEA) |
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Latin America |
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
10.North America Genetic Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Cytogenetic Testing |
10.1.2.Biochemical Testing |
10.1.3.Molecular Testing |
10.2. Sample Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Blood |
10.2.2.Hair |
10.2.3.Saliva |
10.2.4.Others |
10.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Predictive and Presymptomatic Testing |
10.3.2.Carrier Testing |
10.3.3.Prenatal and Newborn Screening |
10.3.4.Pharmacogenomic Testing |
10.3.5.Cancer Screening |
10.3.6.Forensic |
10.3.7.Others |
10.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Hospitals |
10.4.2.Diagnostic Laboratories |
10.4.3.Academic and Research Institutes |
10.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.5.1.United States of America (USA) |
10.5.2.Canada |
11.Europe Genetic Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Cytogenetic Testing |
11.1.2.Biochemical Testing |
11.1.3.Molecular Testing |
11.2. Sample Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Blood |
11.2.2.Hair |
11.2.3.Saliva |
11.2.4.Others |
11.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Predictive and Presymptomatic Testing |
11.3.2.Carrier Testing |
11.3.3.Prenatal and Newborn Screening |
11.3.4.Pharmacogenomic Testing |
11.3.5.Cancer Screening |
11.3.6.Forensic |
11.3.7.Others |
11.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.Hospitals |
11.4.2.Diagnostic Laboratories |
11.4.3.Academic and Research Institutes |
11.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.5.1.Germany |
11.5.2.France |
11.5.3.Italy |
11.5.4.United Kingdom (UK) |
11.5.5.Spain |
12.Asia Pacific (APAC) Genetic Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Cytogenetic Testing |
12.1.2.Biochemical Testing |
12.1.3.Molecular Testing |
12.2. Sample Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Blood |
12.2.2.Hair |
12.2.3.Saliva |
12.2.4.Others |
12.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Predictive and Presymptomatic Testing |
12.3.2.Carrier Testing |
12.3.3.Prenatal and Newborn Screening |
12.3.4.Pharmacogenomic Testing |
12.3.5.Cancer Screening |
12.3.6.Forensic |
12.3.7.Others |
12.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.Hospitals |
12.4.2.Diagnostic Laboratories |
12.4.3.Academic and Research Institutes |
12.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.5.1.China |
12.5.2.India |
12.5.3.Australia and New Zealand (ANZ) |
12.5.4.Japan |
12.5.5.Rest of APAC |
13.Middle East and Africa (MEA) Genetic Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Cytogenetic Testing |
13.1.2.Biochemical Testing |
13.1.3.Molecular Testing |
13.2. Sample Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Blood |
13.2.2.Hair |
13.2.3.Saliva |
13.2.4.Others |
13.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Predictive and Presymptomatic Testing |
13.3.2.Carrier Testing |
13.3.3.Prenatal and Newborn Screening |
13.3.4.Pharmacogenomic Testing |
13.3.5.Cancer Screening |
13.3.6.Forensic |
13.3.7.Others |
13.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Hospitals |
13.4.2.Diagnostic Laboratories |
13.4.3.Academic and Research Institutes |
13.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.5.1.GCC Countries |
13.5.2.South Africa |
13.5.3.Rest of MEA |
14.Latin America Genetic Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
14.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.1.1.Cytogenetic Testing |
14.1.2.Biochemical Testing |
14.1.3.Molecular Testing |
14.2. Sample Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.2.1.Blood |
14.2.2.Hair |
14.2.3.Saliva |
14.2.4.Others |
14.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.3.1.Predictive and Presymptomatic Testing |
14.3.2.Carrier Testing |
14.3.3.Prenatal and Newborn Screening |
14.3.4.Pharmacogenomic Testing |
14.3.5.Cancer Screening |
14.3.6.Forensic |
14.3.7.Others |
14.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.4.1.Hospitals |
14.4.2.Diagnostic Laboratories |
14.4.3.Academic and Research Institutes |
14.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.5.1.Brazil |
14.5.2.Mexico |
14.5.3.Rest of LA |
15. Competition Landscape |
15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
15.2.1.Agilent Technologies |
15.2.2.PerkinElmer, Inc. |
15.2.3.Thermo Fisher Scientific |
15.2.4.Bio-Rad Laboratories |
15.2.5.F. Hoffman La Roche Limited |
15.2.6.Qiagen N.V. |
15.2.7.Abbott Molecular |
15.2.8.Becton, Dickinson and Company |
15.2.9.Hologic, lnc |
15.2.10.Biomerieux |
15.2.11.Illumina |
15.2.12.Diasorin |
16. Research Methodology |
17. Appendix and Abbreviations |
Key Market Players